| Financial Year |
March 31 2023 |
| Monetary Funds |
186,845,007.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
84,742,895.00 |
| Accounts Receivable |
1,154,973,148.75 |
| Advances to Suppliers |
24,101,499.48 |
| Other Receivables |
16,119,620.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
407,470,212.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,993,048.08 |
| Total Current Assets |
2,122,701,091.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,104,849.93 |
| Investment Properties |
-- |
| Fixed Assetes |
623,982,285.45 |
| Under-construction Projects |
83,376,076.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
96,881,373.88 |
| R&D expenses |
-- |
| Goodwill |
167,636,040.92 |
| Long-Term Deferred and Prepaid Expenses |
4,984.09 |
| Deferred Income Tax Assets |
25,747,996.49 |
| Other Non-Current Assets |
24,827,365.76 |
| Sub-Total of Non-Current Assets |
1,036,802,059.91 |
| Total Assets |
3,159,503,151.43 |
| Short-Term Loans |
274,273,633.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,707,914.98 |
| Accounts Payable |
445,874,595.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,743,367.42 |
| Taxes Payable |
17,578,871.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
216,805.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,288,398.75 |
| Other Current Liabilities |
17,581,471.20 |
| Sub-Total of Current Liabilities |
923,738,112.11 |
| Long-term Loans |
66,172,563.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,009,012.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
101,584,012.97 |
| Total Liabilities |
1,025,322,125.08 |
| Paid-In Capital(Or Share Stock) |
601,234,191.00 |
| Capital Surplus |
362,544,130.26 |
| Surplus Reserve |
144,101,857.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
989,877,140.17 |
| Minority Stockholder's Interest |
36,423,706.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,097,757,319.37 |
| Owner's Equity（Stockholder's Equity） |
2,134,181,026.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,159,503,151.43 |
